Literature DB >> 33861683

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2021        PMID： 33861683      PMCID： PMC8078716          DOI： 10.1080/21645515.2021.1905446

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.

Authors:  Emily K Sims; Brian N Bundy; Kenneth Stier; Elisavet Serti; Noha Lim; S Alice Long; Susan M Geyer; Antoinette Moran; Carla J Greenbaum; Carmella Evans-Molina; Kevan C Herold
Journal:  Sci Transl Med       Date:  2021-03-03       Impact factor: 17.956

2.  Bispecific antibodies targeting mutant RAS neoantigens.

Authors:  Jacqueline Douglass; Emily Han-Chung Hsiue; Brian J Mog; Michael S Hwang; Sarah R DiNapoli; Alexander H Pearlman; Michelle S Miller; Katharine M Wright; P Aitana Azurmendi; Qing Wang; Suman Paul; Annika Schaefer; Andrew D Skora; Marco Dal Molin; Maximilian F Konig; Qiang Liu; Evangeline Watson; Yana Li; Michael B Murphy; Drew M Pardoll; Chetan Bettegowda; Nickolas Papadopoulos; Sandra B Gabelli; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Sci Immunol       Date:  2021-03-01

3.  TCR β chain-directed bispecific antibodies for the treatment of T cell cancers.

Authors:  Suman Paul; Alexander H Pearlman; Jacqueline Douglass; Brian J Mog; Emily Han-Chung Hsiue; Michael S Hwang; Sarah R DiNapoli; Maximilian F Konig; Patrick A Brown; Katharine M Wright; Surojit Sur; Sandra B Gabelli; Yana Li; Gabriel Ghiaur; Drew M Pardoll; Nickolas Papadopoulos; Chetan Bettegowda; Kenneth W Kinzler; Shibin Zhou; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2021-03-01       Impact factor: 17.956

4.  Targeting a neoantigen derived from a common TP53 mutation.

Authors:  Emily Han-Chung Hsiue; Katharine M Wright; Jacqueline Douglass; Michael S Hwang; Brian J Mog; Alexander H Pearlman; Suman Paul; Sarah R DiNapoli; Maximilian F Konig; Qing Wang; Annika Schaefer; Michelle S Miller; Andrew D Skora; P Aitana Azurmendi; Michael B Murphy; Qiang Liu; Evangeline Watson; Yana Li; Drew M Pardoll; Chetan Bettegowda; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Sandra B Gabelli; Shibin Zhou
Journal:  Science       Date:  2021-03-01       Impact factor: 47.728

5.  Utility of a safety switch to abrogate CD19.CAR T-cell-associated neurotoxicity.

Authors:  Matthew C Foster; Barbara Savoldo; Winnie Lau; Clio Rubinos; Natalie Grover; Paul Armistead; James Coghill; Robert S Hagan; Kaitlin Morrison; Faith Brianne Buchanan; Catherine Cheng; Spencer Laing; Anastasia Ivanova; John West; Aaron Foster; Jonathan Serody; Gianpietro Dotti
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

6.  Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection.

Authors:  Nick K Jones; Lucy Rivett; Nicholas J Matheson; Michael P Weekes; Shaun Seaman; Richard J Samworth; Ben Warne; Chris Workman; Mark Ferris; Jo Wright; Natalie Quinnell; Ashley Shaw; Ian G Goodfellow; Paul J Lehner; Rob Howes; Giles Wright
Journal:  Elife       Date:  2021-04-08       Impact factor: 8.140
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.